Your session is about to expire
← Back to Search
Cognitive Remediation Therapy for Schizophrenia (RC2S Trial)
RC2S Trial Summary
This trial will investigate whether a cognitive remediation program can be administered remotely to people with schizophrenia and related disorders.
RC2S Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowRC2S Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RC2S Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with schizophrenia or a similar mental health condition.I cannot speak or read French or English.I am 18 years old or older.My doctor thinks I can manage symptoms and use online platforms.You are being followed and treated by a clinician of the Douglas Mental Health University Hospital.I have trouble understanding social cues or emotions, confirmed by a test.I have been diagnosed with schizophrenia or a similar mental health condition.You have access to digital technology, Internet and access to a private space (a room where the participant can be alone).I am 18 years old or older.My doctor thinks I'm stable and can use online platforms.
- Group 1: Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this investigation currently recruiting participants?
"Clinicaltrials.gov indicates that this clinical trial is actively looking for volunteers, with the research campaign first being posted on June 1st 2022 and most recently revised on October 21st 2022."
What do researchers hope to learn by conducting this trial?
"The principal aim of this trial is to assess the effectiveness of Penn Emotion Recognition Task (ER-40) over a predetermined period. In addition, Patient Health Questionnaire (PHQ-9), Davos Assessment of Cognitive Biases Scale (DACOBS), and Positive and Negative Syndrome Scale (PANSS-6) will be used as secondary measures for evaluation; each requiring approximately 5 minutes in administration. PHQ-9 evaluates major depression criteria, DACOBS gauges cognitive biases via Likert scale responses from 1 - 7, while PANSS-6 examines schizophrenic symptoms such as delusions, hallucinations, flat"
How many individuals are engaged in this clinical research?
"Affirmative. Clinicaltrials.gov supports the assertion that this clinical trial is actively recruiting participants, beginning on January 6th 2022 and with its most recent update occurring on October 21st of the same year. The study seeks to recruit 26 individuals from a single medical centre."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger